Bio-printing method as a novel approach to obtain a fibrin scaffold settled by limbal epithelial cells for corneal regeneration.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 Oct 2024
Historique:
received: 07 07 2024
accepted: 17 09 2024
medline: 8 10 2024
pubmed: 8 10 2024
entrez: 7 10 2024
Statut: epublish

Résumé

Treatment of Limbal Stem Cell Deficiency (LSCD), based on autologous transplantation of the patient's stem cells, is one of the few medical stem cell therapies approved by the European Medicines Agency (EMA). It relies on isolating and culturing in vivo Limbal Epithelial Stem Cells (LESC) and then populating them on the fibrin substrate, creating a scaffold for corneal epithelial regeneration. Such a solution is then implanted into the patient's eye. The epithelial cell culture process is specific, and its results strongly depend on the initial cell seeding density. Achieving control of the density and repeatability of the process is a desirable aim and can contribute to the success of the therapy. The study aimed to test bioprinting as a potential technique to increase the control over LESCs seeding on a scaffold and improve process reproducibility. Cells were applied to 0.5 mm thick, flat, transparent fibrin substrates using extrusion bioprinting; the control was the traditional manual application of cells using a pipette. The use of 3D printer enabled uniform coverage of the scaffold surface, and LESCs density in printed lines was close to the targeted value. Moreover, printed cells had higher cell viability than those seeded traditionally (91.1 ± 8.2% vs 82.6 ± 12.8%). The growth rate of the epithelium was higher in bioprinted samples. In both methods, the epithelium had favorable phenotypic features (p63 + and CK14 +). 3D printing constitutes a promising approach in LSCD therapy. It provides favorable conditions for LESCs growth and process reproducibility. Its application may lead to reduced cell requirements, thereby to using fewer cells on lower passages, which will contribute to preserving LESCs proliferative potential.

Identifiants

pubmed: 39375390
doi: 10.1038/s41598-024-73383-y
pii: 10.1038/s41598-024-73383-y
doi:

Substances chimiques

Fibrin 9001-31-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23352

Informations de copyright

© 2024. The Author(s).

Références

Hu, J. C. W. & Trief, D. A narrative review of limbal stem cell deficiency & severe ocular surface disease. Ann. Eye Sci. 8, 13–13 (2023).
doi: 10.21037/aes-22-35
Limbal stem cell deficiency - ORPHA:171673. https://www.orpha.net/en/disease/detail/171673 .
Yokoo, S., Yamagami, S., Usui, T., Amano, S. & Araie, M. Human corneal epithelial equivalents for ocular surface reconstruction in a complete serum-free culture system without unknown factors. Investig. Opthalmology Vis. Sci. 49, 2438 (2008).
doi: 10.1167/iovs.06-1448
Holland, E. J. & Schwartz, G. S. The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system. Cornea. https://doi.org/10.1097/00003226-199611000-00003 (1996).
doi: 10.1097/00003226-199611000-00003 pubmed: 8899265
Lang, S. J., Böhringer, D., Geerling, G. & Reinhard, T. Long-term results of allogenic penetrating limbo-keratoplasty: 20 years of experience. Eye 31, 372–378 (2017).
pubmed: 27768117 doi: 10.1038/eye.2016.217
Kolli, S., Ahmad, S., Lako, M. & Figueiredo, F. Successful clinical implementation of corneal epithelial stem cell therapy for treatment of unilateral limbal stem cell deficiency. Stem Cells 28, 597–610 (2010).
pubmed: 20014040 doi: 10.1002/stem.276
Guérin, L.-P. et al. Cultured autologous corneal epithelia for the treatment of unilateral limbal stem cell deficiency: a case series of 15 patients. Biomedicines 10, 1958 (2022).
pubmed: 36009509 pmcid: 9405734 doi: 10.3390/biomedicines10081958
Pellegrini, G. et al. Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J. Cell Biol. 145, 769–782 (1999).
pubmed: 10330405 pmcid: 2133195 doi: 10.1083/jcb.145.4.769
Pellegrini, G. et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349, 990–993 (1997).
pubmed: 9100626 doi: 10.1016/S0140-6736(96)11188-0
Schwab, I. R., Reyes, M. & Isseroff, R. R. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 19, 421–426 (2000).
pubmed: 10928750 doi: 10.1097/00003226-200007000-00003
Tsai, R.J.-F., Li, L.-M. & Chen, J.-K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N. Engl. J. Med. 343, 86–93 (2000).
pubmed: 10891515 doi: 10.1056/NEJM200007133430202
Sangwan, V. S., Vemuganti, G. K., Singh, S. & Balasubramanian, D. Successful reconstruction of damaged ocular outer surface in humans using limbal and conjuctival stem cell culture methods. Biosci. Rep. 23, 169–174 (2003).
pubmed: 14748537 doi: 10.1023/B:BIRE.0000007690.43273.73
Ramos, T., Scott, D. & Ahmad, S. An update on ocular surface epithelial stem cells: cornea and conjunctiva. Stem Cells Int. 2015, 1–7 (2015).
doi: 10.1155/2015/601731
Di Iorio, E. et al. Techniques for culture and assessment of limbal stem cell grafts. Ocul. Surf. 8, 146–153 (2010).
pubmed: 20712971 doi: 10.1016/S1542-0124(12)70225-2
Rama, P. et al. Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 363, 147–155 (2010).
pubmed: 20573916 doi: 10.1056/NEJMoa0905955
Pellegrini, G. & De Luca, M. Eyes on the prize: limbal stem cells and corneal restoration. Cell Stem Cell 15, 121–122 (2014).
pubmed: 25105577 doi: 10.1016/j.stem.2014.07.011
Pedrotti, E. et al. In vivo confocal microscopy 1 year after autologous cultured limbal stem cell grafts. Ophthalmology 122, 1660–1668 (2015).
pubmed: 26050542 doi: 10.1016/j.ophtha.2015.04.004
Rama, P. et al. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 72, 1478–1485 (2001).
pubmed: 11707733 doi: 10.1097/00007890-200111150-00002
Ahmed, T. A. E., Dare, E. V. & Hincke, M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng. Part B Rev. 14, 199–215 (2008).
pubmed: 18544016 doi: 10.1089/ten.teb.2007.0435
Sangwan, V. S. et al. Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: a 10-year study. Br. J. Ophthalmol. 95, 1525–1529 (2011).
pubmed: 21890785 doi: 10.1136/bjophthalmol-2011-300352
Forni, M. F. et al. Comparison between different biomaterial scaffolds for limbal-derived stem cells growth and enrichment. Curr. Eye Res. 38, 27–34 (2013).
pubmed: 23051105 doi: 10.3109/02713683.2012.733053
He, N. et al. Extracellular matrix can recover the downregulation of adhesion molecules after cell detachment and enhance endothelial cell engraftment. Sci. Rep. 5, 10902 (2015).
pubmed: 26039874 pmcid: 4454140 doi: 10.1038/srep10902
Wright, B., Mi, S. & Connon, C. J. Towards the use of hydrogels in the treatment of limbal stem cell deficiency. Drug Discov. Today 18, 79–86 (2013).
pubmed: 22846850 pmcid: 4046643 doi: 10.1016/j.drudis.2012.07.012
Jeffries, G. D. M. et al. 3D micro-organisation printing of mammalian cells to generate biological tissues. Sci. Rep. 10, 19529 (2020).
pubmed: 33173097 pmcid: 7656262 doi: 10.1038/s41598-020-74191-w
Pramotton, F. M. et al. Optimized topological and topographical expansion of epithelia. ACS Biomater. Sci. Eng. 5, 3922–3934 (2019).
pubmed: 33438431 doi: 10.1021/acsbiomaterials.8b01346
Cubo, N., Garcia, M., Del Cañizo, J. F., Velasco, D. & Jorcano, J. L. 3D bioprinting of functional human skin: production and in vivo analysis. Biofabrication 9, 015006 (2016).
pubmed: 27917823 doi: 10.1088/1758-5090/9/1/015006
DenizDerman, I. et al. High-throughput bioprinting of the nasal epithelium using patient-derived nasal epithelial cells. Biofabrication 15, 044103 (2023).
doi: 10.1088/1758-5090/aced23
Pellegrini, G. et al. From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU. Regen. Med. 11, 407–420 (2016).
pubmed: 27091398 pmcid: 5561870 doi: 10.2217/rme-2015-0051
Pellegrini, G. et al. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. 98, 3156–3161 (2001).
pubmed: 11248048 pmcid: 30623 doi: 10.1073/pnas.061032098
Sharifi, A. M., Darabi, R. & Jadidi, K. Isolation, culture, characterization and optimization of human corneal stem cells.. Biocell Off J. Soc. Latinoam. Microsc. Electron. Al 34, 53–55 (2010).
Chen, Z. et al. Characterization of putative stem cell phenotype in human limbal epithelia. STEM CELLS 22, 355–366 (2004).
pubmed: 15153612 doi: 10.1634/stemcells.22-3-355
Kurpakus, M. A., Maniaci, M. T. & Esco, M. Expression of keratins K12, K4 and K14 during development of ocular surface epithelium. Curr. Eye Res. 13, 805–814 (1994).
pubmed: 7531631 doi: 10.3109/02713689409025135
Schlötzer-Schrehardt, U. & Kruse, F. E. Identification and characterization of limbal stem cells. Exp. Eye Res. 81, 247–264 (2005).
pubmed: 16051216 doi: 10.1016/j.exer.2005.02.016
Yang, A. et al. p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2, 305–316 (1998).
pubmed: 9774969 doi: 10.1016/S1097-2765(00)80275-0
Di Iorio, E. et al. Isoforms of ΔNp63 and the migration of ocular limbal cells in human corneal regeneration. Proc. Natl. Acad. Sci. 102, 9523–9528 (2005).
pubmed: 15983386 pmcid: 1172259 doi: 10.1073/pnas.0503437102
Barbaro, V. et al. C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. J. Cell Biol. 177, 1037–1049 (2007).
pubmed: 17562792 pmcid: 2064364 doi: 10.1083/jcb.200703003
Zakaria, N. et al. Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation. J. Transl. Med. 12, 58 (2014).
pubmed: 24589151 pmcid: 3996015 doi: 10.1186/1479-5876-12-58
Ekpo, P. et al. Characterization of limbal explant sites: optimization of stem cell outgrowth in in vitro culture. PLOS ONE 15, e0233075 (2020).
pubmed: 32407348 pmcid: 7224544 doi: 10.1371/journal.pone.0233075
Crespo-Moral, M., García-Posadas, L., López-García, A. & Diebold, Y. Histological and immunohistochemical characterization of the porcine ocular surface. PLOS ONE 15, e0227732 (2020).
pubmed: 31929592 pmcid: 6957219 doi: 10.1371/journal.pone.0227732
Seyed-Safi, A. G. & Daniels, J. T. A validated porcine corneal organ culture model to study the limbal response to corneal epithelial injury. Exp. Eye Res. 197, 108063 (2020).
pubmed: 32417262 doi: 10.1016/j.exer.2020.108063
Notara, M., Schrader, S. & Daniels, J. T. The porcine limbal epithelial stem cell niche as a new model for the study of transplanted tissue-engineered human limbal epithelial cells. Tissue Eng. Part A 17, 741–750 (2011).
pubmed: 20929285 doi: 10.1089/ten.tea.2010.0343
Malekpour, A. & Chen, X. Printability and cell viability in extrusion-based bioprinting from experimental, computational, and machine learning views. J. Funct. Biomater. 13, 40 (2022).
pubmed: 35466222 pmcid: 9036289 doi: 10.3390/jfb13020040
Naghieh, S. & Chen, X. Printability–A key issue in extrusion-based bioprinting. J. Pharm. Anal. 11, 564–579 (2021).
pubmed: 34765269 pmcid: 8572712 doi: 10.1016/j.jpha.2021.02.001
Lužnik, Z. et al. Towards xeno-free cultures of human limbal stem cells for ocular surface reconstruction. Cell Tissue Bank. 18, 461–474 (2017).
pubmed: 28550448 doi: 10.1007/s10561-017-9632-7
Farooqui, R. & Fenteany, G. Multiple rows of cells behind an epithelial wound edge extend cryptic lamellipodia to collectively drive cell-sheet movement. J. Cell Sci. 118, 51–63 (2005).
pubmed: 15585576 doi: 10.1242/jcs.01577
Green, H. The birth of therapy with cultured cells. BioEssays 30, 897–903 (2008).
pubmed: 18693268 doi: 10.1002/bies.20797
De Luca, M., Pellegrini, G. & Green, H. Regeneration of squamous epithelia from stem cells of cultured grafts. Regen. Med. 1, 45–57 (2006).
pubmed: 17465819 doi: 10.2217/17460751.1.1.45
Sejpal, K. et al. Cultivated limbal epithelial transplantation in children with ocular surface burns. JAMA Ophthalmol. 131, 731 (2013).
pubmed: 23559315 doi: 10.1001/jamaophthalmol.2013.2308
Mladenovska, T., Choong, P. F., Wallace, G. G. & O’Connell, C. D. The regulatory challenge of 3D bioprinting. Regen. Med. 18, 659–674 (2023).
pubmed: 37403962 doi: 10.2217/rme-2022-0194

Auteurs

Krzysztof Pietryga (K)

Silesian Park of Medical Technology Kardio-Med Silesia, M. Curie-Skłodowskiej 10C, 41-800, Zabrze, Poland.

Katarzyna Jesse (K)

Silesian Park of Medical Technology Kardio-Med Silesia, M. Curie-Skłodowskiej 10C, 41-800, Zabrze, Poland.

Rafał Drzyzga (R)

Silesian Park of Medical Technology Kardio-Med Silesia, M. Curie-Skłodowskiej 10C, 41-800, Zabrze, Poland.

Adam Konka (A)

Silesian Park of Medical Technology Kardio-Med Silesia, M. Curie-Skłodowskiej 10C, 41-800, Zabrze, Poland.

Joanna Zembala-John (J)

Acellmed, M. Curie-Skłodowskiej 10C, 41-800, Zabrze, Poland.
Department of Medicine and Environmental Epidemiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, H. Jordana 19, 41-808, Zabrze, Poland.

Aleksandra Kowalik (A)

Acellmed, M. Curie-Skłodowskiej 10C, 41-800, Zabrze, Poland.

Zdzisław Kiełbowicz (Z)

Department and Clinic of Surgery, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.

Marek Ćwirko (M)

Ophthalmology Clinical Centre SPEKTRUM, ul. Zaolziańska 4, Wroclaw, Poland.

Rafał J Bułdak (RJ)

Acellmed, M. Curie-Skłodowskiej 10C, 41-800, Zabrze, Poland.
Department of Clinical Biochemistry and Laboratory Diagnostics, Institute of Medical Sciences, University of Opole, Oleska 48, 45-052, Opole, Poland.

Dariusz Dobrowolski (D)

Chair and Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Panewnicka 65, 40-760, Katowice, Poland. dardobmd@wp.pl.
Department of Ophthalmology, Trauma Center, St. Barbara Hospital, Medyków Square 1, 41-200, Sosnowiec, Poland. dardobmd@wp.pl.

Edward Wylęgała (E)

Chair and Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Panewnicka 65, 40-760, Katowice, Poland.
Chair Vice-Rector for Development and Technology Transfer (Chair End Ophthalmology Departament in Faculty of Medical Sciences in Zabrze, Railway Hospital in Katowice), Katowice, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH